Cargando…
Bone marrow CD3 (+) CD56 (+) regulatory T lymphocytes (T(R3) (−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
BACKGROUND: Emergence of dysplastic haematopoietic precursor/s, cytopenia and variable leukaemia risk characterise myelodysplastic syndromes (MDS). Impaired immune‐regulation, preferentially affecting cytotoxic T cells (CTL), has been largely observed in MDS. Recently, we described the T(R3−56) T ce...
Autores principales: | Leone, Stefania, Rubino, Valentina, Palatucci, Anna Teresa, Giovazzino, Angela, Carriero, Flavia, Cerciello, Giuseppe, Pane, Fabrizio, Ruggiero, Giuseppina, Terrazzano, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543123/ https://www.ncbi.nlm.nih.gov/pubmed/35775392 http://dx.doi.org/10.1111/ejh.13822 |
Ejemplares similares
-
T1D progression is associated with loss of
CD3(+)CD56(+) regulatory T cells that control
CD8(+) T cell effector functions
por: Terrazzano, Giuseppe, et al.
Publicado: (2020) -
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
por: Terrazzano, Giuseppe, et al.
Publicado: (2020) -
The osteogenic commitment of CD271+CD56+ bone marrow stromal cells (BMSCs) in osteoarthritic femoral head bone
por: Ilas, Dragos C., et al.
Publicado: (2020) -
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease
por: Rubino, Valentina, et al.
Publicado: (2023) -
Extraordinarily elevated CD33 expression in CD56(+)CD3(–) cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report
por: Wang, Dongyao, et al.
Publicado: (2021)